Related Experiment Video
Updated: Jan 30, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.7K
Regulatory T Cells in Gynecologic Cancer
Yang Ou1, Martin J Cannon2, Mayumi Nakagawa1
1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
MOJ Immunology
|January 15, 2019
Summary
Regulatory T cells (Tregs) in cancer patients are linked to worse outcomes and immune evasion. Targeting Tregs may improve cancer immunotherapy effectiveness.
Area of Science:
- Immunology
- Oncology
- Gynecologic Oncology
Background:
- Regulatory T cells (Tregs) are increasingly recognized as key players in cancer immune evasion.
- Elevated Treg levels in tumors and patient samples correlate with poor cancer prognosis.
Purpose of the Study:
- To review the mechanisms of Treg function in cancer.
- To describe the specific roles of Tregs in the tumor microenvironment of cervical, vulvar, and ovarian cancers.
- To discuss the relationship between Tregs and clinical immunotherapy outcomes.
Main Methods:
- Literature review of Treg mechanisms and roles in gynecologic cancers.
- Analysis of Treg correlations with clinical immunotherapeutic study results.
Main Results:
- Tregs are significant mediators of active immune evasion in cancer.
- Treg presence is associated with poor prognosis across various cancer sites, including gynecologic malignancies.
- The tumor microenvironment is heavily influenced by Treg activity.
Conclusions:
- Understanding Treg mechanisms is crucial for cancer treatment.
- Modulating Tregs holds significant potential for enhancing the efficacy of cancer immunotherapies.
- Targeting Tregs could represent a promising strategy in gynecologic oncology.
Related Concept Videos
02:02Cis-regulatory Sequences
11.8K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.8K
02:02Cis-regulatory Sequences
4.1K
4.1K
01:28Global Regulatory Systems
667
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
667
01:35Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
556
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
556